Publications

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jillian Romeo2021-07-27T10:37:57-04:00

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJillian Romeo2021-07-27T10:37:57-04:00

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation

Jillian Romeo2021-07-26T18:16:43-04:00

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationJillian Romeo2021-07-26T18:16:43-04:00

Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma

Jillian Romeo2021-07-14T18:31:27-04:00

Bempegaldesleukin Plus Nivolumab in First-Line Metastatic MelanomaJillian Romeo2021-07-14T18:31:27-04:00

Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectors

Jillian Romeo2021-07-14T19:02:25-04:00

Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsJillian Romeo2021-07-14T19:02:25-04:00

NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells

Jillian Romeo2021-07-08T10:20:35-04:00

NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK CellsJillian Romeo2021-07-08T10:20:35-04:00

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Jillian Romeo2021-04-27T23:15:39-04:00

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19Jillian Romeo2021-04-27T23:15:39-04:00

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity

Jillian Romeo2021-04-27T23:15:40-04:00

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activityJillian Romeo2021-04-27T23:15:40-04:00

Complement‐activated human endothelial cells stimulate increased polyfunctionality in alloreactive T cells.

[email protected]2021-04-27T23:15:40-04:00

Complement‐activated human endothelial cells stimulate increased polyfunctionality in alloreactive T cells.[email protected]2021-04-27T23:15:40-04:00

Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19.

[email protected]2021-04-27T23:15:41-04:00

Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19.[email protected]2021-04-27T23:15:41-04:00

Progression-free Survival and Biomarker Correlates of Response With BEMPEG Plus NIVO in Previously Untreated Patients With Metastatic Melanoma: Results From The PIVOT-02 Study.

Jillian Romeo2021-04-27T23:15:41-04:00

Progression-free Survival and Biomarker Correlates of Response With BEMPEG Plus NIVO in Previously Untreated Patients With Metastatic Melanoma: Results From The PIVOT-02 Study.Jillian Romeo2021-04-27T23:15:41-04:00